Latest Articles in Healthcare
Drugmaker Sanofi To Raise Over $11 Billion Via Sale Of Regeneron Shares
Sanofi is selling the Regeneron shares at $515.00 per share - a discount of around 5.5% to Regeneron's closing price of $545.21 on May 26, and raising gross proceeds of $11.1 billion.
Read More
Rising Swiss Rivalry As Roche And Novartis Target Same Diseases
Roche Chief Executive Severin Schwan is looking beyond cancer drugs to fresh treatment areas, while Novartis CEO Vas Narashiman bulks up in the same territory.
Read More
Lilly, Junshi Biosciences Plan To Start Human Trials Of COVID-19 Antibody In Q2
Lilly and several other drugmakers such as Gilead Sciences, Pfizer Inc and Merck & Co Inc are racing to develop treatments or vaccines for the fast-spreading respiratory illness caused by the novel coronavirus.
Read More
India's Glenmark To Study Potential COVID-19 Drug Combination
Glenmark said it would conduct clinical trials in India of just favipiravir as a potential treatment for COVID-19.
Read More
Highest Spike of 6,977 COVID-19 Cases; India Now Among Top 10 Countries As Tally Reaches 1,38,845
India is now among the top 10 countries in the world regarding the total number of COVID-19 cases.
Read More
The Jab The World Awaits
The race to create a vaccine is on – the country that gets there first stands to gain in more ways than one By Jyotsna Sharma
Read More
Human Trials Of British Coronavirus Vaccine To Reach 10,000
Institutions across Britain had begun enrolling up to 10,260 adults and children to see how well the human immune system responds to the vaccine and how safe it is
Read More
Strides Pharma To Conduct Trials In India For Potential COVID-19 Drug
The Bengaluru-based company has received approval from the Drug Controller General of India to conduct human studies of favipiravir in the country, a Strides executive said on a post-earnings conference call.
Read More
Dr Reddy's Q4 Profit Jumps 76% To Rs 764 Crore On Higher Sales In US, Europe
The company reported a revenue of Rs 4,432 crore, up 10 per cent from the year-ago period.
Read More
Here’s How Ayushman Bharat Is Enabling The Fight Against COVID
In an interview with BW Businessworld, Dr. Vipul Aggarwal, Deputy CEO, National Health Authority, talks about India’s first and the world’s largest healthcare scheme that covers about 40% of the country’s population and it’s role is fighting COVID 19.
Read More
JP Nadda Lauds Efforts Of Medical Workers In Making Ayushman Bharat A Success
The BJP chief also expressed his gratitude towards health workers and other paramedical staff for making Ayushman Bharat a success.
Read More
Moderna Expects Mid-stage Trials For COVID-19 Vaccine To Begin Shortly
The drug developer had previously said it expected mid-stage trials to begin in the current quarter, with the aim to start late-stage studies in the fall.
Read More
Coronavirus Vaccine From Moderna Appears Safe, Shows Promise In Data From 8 People
The Moderna vaccine is one of more than 100 under development intended to protect against the novel coronavirus that has infected more than 4.7 million people globally and killed over 317,000.
Read More
GSK's Long-Acting Injection Beats Truvada In HIV Prevention Trial
Truvada generated $2.8 billion in sales last year, both from treatment and preventing an HIV infection.
Read More
Novartis CEO Says Any New Coronavirus Vaccine Will Take Two Years
But experts have said no vaccine is expected to be ready for use until at least 2021, as they must be widely tested in humans before being administered to hundreds of millions, if not billions, of people to prevent infection.
Read More